Inventor · disambiguated record
Genmin Lu
Also filed as: LU GENMIN
20 granted patents·24 pending applications·285 citations·filing 2008–2024
96Inventor score
Top patents by PatentIndex Score
44 records- 0197US8153590B2Antidotes for factor Xa inhibitors and methods of using the sameLU GENMIN·Filed 2008·Granted Apr 10, 2012·56 cites·18 claims
- 0296US8268783B2Antidotes for factor Xa inhibitors and methods of using the sameSINHA UMA·Filed 2010·Granted Sep 18, 2012·40 cites·25 claims
- 0395US9388401B2Antidotes for factor Xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2014·Granted Jul 12, 2016·18 cites·19 claims
- 0495US9062298B2Antidotes for factor XA inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2013·Granted Jun 23, 2015·21 cites·18 claims
- 0595US8889129B2Antidotes for factor Xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2013·Granted Nov 18, 2014·18 cites·22 claims
- 0695US8455441B2Antidotes for factor Xa inhibitors and methods of using the sameLU GENMIN·Filed 2012·Granted Jun 4, 2013·27 cites·18 claims
- 0794US10954503B2Antidotes for factor Xa inhibitors and methods of using the sameALEXION PHARMA INC·Filed 2019·Granted Mar 23, 2021·4 cites·12 claims
- 0894US10954504B2Preparation of factor Xa derivativesALEXION PHARMA INC·Filed 2020·Granted Mar 23, 2021·4 cites·14 claims
- 0994US9109046B2Antidotes for factor Xa inhibitors and methods of using the sameSINHA UMA·Filed 2012·Granted Aug 18, 2015·21 cites·17 claims
- 1094US8455439B2Antidotes for factor Xa inhibitors and methods of using the same in combination with blood coagulating agentsLU GENMIN·Filed 2009·Granted Jun 4, 2013·32 cites·13 claims
- 1193US9587233B2Antidotes for factor XA inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2015·Granted Mar 7, 2017·10 cites·7 claims
- 1292US9056106B2Unit dose formulation of antidotes for factor Xa inhibitors and methods of using the sameSINHA UMA·Filed 2010·Granted Jun 16, 2015·20 cites·8 claims
- 1391US10675335B2Antidotes for factor Xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2016·Granted Jun 9, 2020·3 cites·3 claims
- 1490US10765726B2Unit dose formulation of antidotes for factor Xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2017·Granted Sep 8, 2020·3 cites·20 claims
- 1588US2024082367A1Antidotes for factor xa inhibitors and methods of using the sameALEXION PHARMA INC·Filed 2023·Application pending·0 cites
- 1688US2025186563A1Unit dose formulation of antidotes for factor xa inhibitors and methods of using the sameALEXION PHARMA INC·Filed 2024·Application pending·0 cites
- 1787US11845966B2Preparation of factor Xa derivativesALEXION PHARMA INC·Filed 2021·Granted Dec 19, 2023·1 cites·13 claims
- 1886US11839646B2Antidotes for factor Xa inhibitors and methods of using the sameALEXION PHARMA INC·Filed 2020·Granted Dec 12, 2023·1 cites·12 claims
- 1986US10190111B2Antidotes for factor Xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2017·Granted Jan 29, 2019·3 cites·10 claims
- 2086US2023383276A1Process for making recombinant antidote to factor xa inhibitorALEXION PHARMA INC·Filed 2023·Application pending·0 cites
- 2185US2024189401A1Unit dose formulation of antidotes for factor xa inhibitors and methods of using the sameALEXION PHARMA INC·Filed 2023·Application pending·0 cites
- 2283US2024076642A1Preparation of factor xa derivativesALEXION PHARMA INC·Filed 2023·Application pending·0 cites
- 2382US10604748B2Preparation of factor Xa derivativesPORTOLA PHARM INC·Filed 2017·Granted Mar 31, 2020·3 cites·27 claims
- 2479US2025092380A1Antidotes to factor xa inhibitorsALEXION PHARMA INC·Filed 2024·Application pending·0 cites
- 2578US2022098565A1Process for making recombinant antidote to factor xa inhibitorALEXION PHARMA INC·Filed 2021·Application pending·0 cites
- 2677US2023000957A1Unit dose formulation of antidotes for factor xa inhibitors and methods of using the sameALEXION PHARMA INC·Filed 2022·Application pending·0 cites
- 2775US2021340515A1Antidotes for factor xa inhibitors and methods of using the sameALEXION PHARMA INC·Filed 2021·Application pending·0 cites
- 2871US2019127720A1Process for making recombinant antidote to factor xa inhibitorPORTOLA PHARM INC·Filed 2018·Application pending·0 cites
- 2971US2021085762A1Unit dose formulation of antidotes for factor xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2020·Application pending·0 cites
- 3068US12195774B2Antidotes to factor XA inhibitorsALEXION PHARMA INC·Filed 2019·Granted Jan 14, 2025·0 cites·4 claims
- 3167US2021379163A1Inhibition of tissue factor pathway inhibitor with factor xa derivativesALEXION PHARMA INC·Filed 2021·Application pending·0 cites
- 3266US2017240879A1Process for making recombinant antidote to factor xa inhibitorPORTOLA PHARM INC·Filed 2016·Application pending·0 cites
- 3366US2020129597A1MODULATION OF FACTOR Xa INHIBITOR-MEDIATED BLOOD LOSS BY PARTIAL AND TRANSIENT ADMINISTRATION OF ANTIDOTEPORTOLA PHARM INC·Filed 2019·Application pending·0 cites
- 3465US2013230901A1Process for making recombinant antidote to factor xa inhibitorPORTOLA PHARM INC·Filed 2013·Application pending·0 cites
- 3565US2017014492A1Unit dose formulation of antidotes for factor xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2016·Application pending·0 cites
- 3663US2015352194A1Inhibition of tissue factor pathway inhibitor with factor xa derivativesPORTOLA PHARM INC·Filed 2013·Application pending·0 cites
- 3763US2015376592A1Process for making recombinant antidote to factor xa inhibitorPORTOLA PHARM INC·Filed 2015·Application pending·0 cites
- 3863US2015025011A1Unit dose formulation of antidotes for factor xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2014·Application pending·0 cites
- 3963US2018333469A1Inhibition of tissue factor pathway inhibitor with factor xa derivativesPORTOLA PHARM INC·Filed 2018·Application pending·0 cites
- 4061US2018185459A1MODULATION OF FACTOR Xa INHIBITOR-MEDIATED BLOOD LOSS BY PARTIAL AND TRANSIENT ADMINISTRATION OF ANTIDOTEPORTOLA PHARM INC·Filed 2018·Application pending·0 cites
- 4158US2023265483A1Methods for testing andexanet potencyALEXION PHARMA INC·Filed 2021·Application pending·0 cites
- 4254US12398387B2Compositions and methods for preparing factor Xa and derivativesALEXION PHARMA INC·Filed 2020·Granted Aug 26, 2025·0 cites·14 claims
- 4351US2014134151A1Antidotes for factor xa inhibitors and methods of using the same in combination with blood coagulating agentsPORTOLA PHARM INC·Filed 2013·Application pending·0 cites
- 4446US2015239929A1Method for purification of recombinant factor xa derivativesPORTOLA PHARM INC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Genmin Lu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →